Genethon SA - Product Pipeline Review - 2016


Posted April 13, 2017 by Shirley

MarketResearchReportStore adds "Genethon SA - Product Pipeline Review - 2016" latest studies, published in March 2017. It is a professional and in-depth study on the current state.

 
MarketResearchReportStore adds "Genethon SA - Product Pipeline Review - 2016" latest studies, published in March 2017. It is a professional and in-depth study on the current state.

For a sample of this report, please email at: [email protected]

Description
Summary
‘Genethon SA - Product Pipeline Review - 2016’, provides an overview of the Genethon SA’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Genethon SA, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Genethon SA
- The report provides overview of Genethon SA including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Genethon SA’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Genethon SA’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Request Sample Copy, please email at: [email protected]

Table Of Contents
Genethon SA Snapshot 6
Genethon SA Overview 6
Key Facts 6
Genethon SA - Research and Development Overview 7
Key Therapeutic Areas 7
Genethon SA - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Genethon SA - Pipeline Products Glance 14
Genethon SA - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Genethon SA - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Genethon SA - Drug Profiles 17
Cell Therapy to Activate FANC-A for Fanconi Anemia - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
CPK-850 - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
G-1XCGD - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Gene Therapy for Duchenne Muscular Dystrophy - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Gene Therapy for Sickle Cell Disease - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Gene Therapy to Activate Dysferlin for Dysferlinopathies - Drug Profile 23
Product Description 23
Mechanism Of Action 23

Browse Complete Report with TOC @
https://www.marketresearchreportstore.com/shop/genethon-sa-product-pipeline-review-2016

For report sample or more information, please feel free to contact us:
Shirley | Sales Director
Call: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Us
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Marketing , Reports
Last Updated April 13, 2017